Clinical Trials : Acute Leukemia of Ambiguous Lineage

Recruiting

Nombre del estudio: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Condición:

Acute Biphenotypic Leukemia
de Novo Myelodysplastic Syndrome Fecha: 2014-01-22
Intervenciones:
- Drug: Cladribine Given IV

Recruiting

Nombre del estudio: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
Condición:

Acute Biphenotypic Leukemia
Adult Acute Lymphoblastic Leukemia
Fecha: 2008-11-21
Intervenciones:
- Drug: Cyclosporine Given IV or

Recruiting

Nombre del estudio: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Condición:

Acute Biphenotypic Leukemia
Acute Myeloid Leukemia Arising From
Fecha: 2008-07-19
Intervenciones:
- Drug: Cyclophosphamide Given I

Suspended

Nombre del estudio: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
Condición:

Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Aggres
Fecha: 2008-07-25
Intervenciones:
- Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Recruiting

Nombre del estudio: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
Condición:

Myelodysplastic Syndrome (MDS)
Chronic Lymphocytic Leukemia (CLL)
Drug: Fludarabine

Completed

Nombre del estudio: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Condición: Leukemia
Fecha: 2011-09-08
Intervenciones:

Drug: multikinase inhibitor AT9283
Other:

Completed

Nombre del estudio: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation
Condición:

Leukemia
Lymphoma
Allogeneic Haematopoietic Stem Cell Tran
Fecha: 2009-10-02
Intervenciones:
- Drug: Busulfan Test Dose 32 mg

Not yet recruiting

Nombre del estudio: Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
Condición: Hematologic Malignancy
Fecha: 2016-03-16
Intervenciones:

Drug: Fludarabine

Completed

Nombre del estudio: Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML)
Condición: Leukemia
Fecha: 2014-04-14
Intervenciones:

Drug: Cladribine

Completed

Nombre del estudio: Venetoclax Combined With Azactidine in the Treatment of ALAL
Condición:
Fecha: 2025-11-04
Intervenciones: Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-28);

Buscar resultados de ensayos clínicos

Acute Leukemia of Ambiguous Lineage - 21 Studies Found

Estado	Estudiar
Recruiting	Nombre del estudio: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes Condición: Acute Biphenotypic Leukemia de Novo Myelodysplastic Syndrome Fecha: 2014-01-22 Intervenciones: Drug: Cladribine Given IV
Recruiting	Nombre del estudio: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant Condición: Acute Biphenotypic Leukemia Adult Acute Lymphoblastic Leukemia Fecha: 2008-11-21 Intervenciones: Drug: Cyclosporine Given IV or
Recruiting	Nombre del estudio: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease Condición: Acute Biphenotypic Leukemia Acute Myeloid Leukemia Arising From Fecha: 2008-07-19 Intervenciones: Drug: Cyclophosphamide Given I
Suspended	Nombre del estudio: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Condición: Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Aggres Fecha: 2008-07-25 Intervenciones: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Recruiting	Nombre del estudio: HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Condición: Myelodysplastic Syndrome (MDS) Chronic Lymphocytic Leukemia (CLL) Drug: Fludarabine
Completed	Nombre del estudio: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia Condición: Leukemia Fecha: 2011-09-08 Intervenciones: Drug: multikinase inhibitor AT9283 Other:
Completed	Nombre del estudio: Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation Condición: Leukemia Lymphoma Allogeneic Haematopoietic Stem Cell Tran Fecha: 2009-10-02 Intervenciones: Drug: Busulfan Test Dose 32 mg
Not yet recruiting	Nombre del estudio: Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies Condición: Hematologic Malignancy Fecha: 2016-03-16 Intervenciones: Drug: Fludarabine
Completed	Nombre del estudio: Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) Condición: Leukemia Fecha: 2014-04-14 Intervenciones: Drug: Cladribine
Completed	Nombre del estudio: Venetoclax Combined With Azactidine in the Treatment of ALAL Condición: Fecha: 2025-11-04 Intervenciones: Venetoclax orally once daily (100 mg d1, 200 mg d2, 400 mg d3-28);